Unknown

Dataset Information

Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.


ABSTRACT:

Background

The mucosa serves as the first defence against pathogens and facilitates the surveillance and elimination of symbiotic bacteria by mucosal immunity. Recently, the mRNA vaccine against SARS-CoV-2 has been demonstrated to induce secretory antibodies in the oral and nasal cavities in addition to a systemic immune response. However, the mechanism of induced immune stimulation effect on mucosal immunity and commensal bacteria profile remains unclear.

Methods

Here, we longitudinally analysed the changing nasal microbiota and both systemic and nasal immune response upon SARS-CoV-2 mRNA vaccination, and evaluated how mRNA vaccination influenced nasal microbiota in 18 healthy participants who had received the third BNT162b.

Results

The nasal S-RBD IgG level correlat

SUBMITTER: Ishizaka A 

PROVIDER: S-EPMC10339591 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature